Leishmaniasis vaccination: targeting the source of infection
- PMID: 11489957
- PMCID: PMC2193470
- DOI: 10.1084/jem.194.3.f7
Leishmaniasis vaccination: targeting the source of infection
Comment on
-
Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein.J Exp Med. 2001 Aug 6;194(3):331-42. doi: 10.1084/jem.194.3.331. J Exp Med. 2001. PMID: 11489952 Free PMC article.
References
-
- Reiner S.L., Locksley R.M. The regulation of immunity to Leishmania major . Annu. Rev. Immunol. 1995;13:151–177. - PubMed
-
- Titus R.G., Ribeiro J.M. Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity. Science. 1988;239:1306–1308. - PubMed
-
- Lanzaro G.C., Lopes A.H., Ribeiro J.M., Shoemaker C.B., Warburg A., Soares M., Titus R.G. Variation in the salivary peptide, maxadilan, from species in the Lutzomyia longipalpis complex. Insect Mol. Biol. 1999;8:267–275. - PubMed
-
- Barral-Netto M., Barral A., Brownell C.E., Skeiky Y.A.W., Ellingsworth L.R., Twardzik D.R., Reed S.G. Transforming growth factor-β in leishmanial infectionan important parasite escape mechanism. Science. 1992;257:545–548. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
